In a 62-year-old woman with end-stage renal disease (estimated glomerular filtration rate ≈11 mL/min/1.73 m²) and chronic kidney disease, what is the optimal oral cardiovascular medication for chest pain (angina)? | Rounds In a 62-year-old woman with end-stage renal disease (estimated glomerular filtration rate ≈11 mL/min/1.73 m²) and chronic kidney disease, what is the optimal oral cardiovascular medication for chest pain (angina)? | Rounds
Loading...

In a 62-year-old woman with end-stage renal disease (estimated glomerular filtration rate ≈11 mL/min/1.73 m²) and chronic kidney disease, what is the optimal oral cardiovascular medication for chest pain (angina)?

Medical Advisory Board
All articles are reviewed for accuracy by our Medical Advisory Board.

Educational purpose only · Not a substitute for professional judgment or the full text of guidelines and labels.

Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2026 · View editorial policy

Long-Acting Oral Nitrates for Chronic Angina Symptom Relief

For chronic angina symptom relief in patients with chronic coronary disease, oral long-acting nitrates (eg, isosorbide mononitrate or isosorbide dinitrate) are recommended as antianginal therapy. [1][2]

Medication Selection Algorithm

  • Beta blockers (eg, metoprolol, carvedilol) are recommended antianginal options for angina symptom relief. [1][3]
  • Calcium channel blockers (eg, non-dihydropyridine CCBs or dihydropyridine CCBs depending on clinical context) are recommended antianginal options for angina symptom relief. [1][3]
  • Long-acting nitrates (oral) are recommended antianginal options for relief of angina symptoms. [1][3]

Optimal Choice in End-Stage Renal Disease Context

When selecting an oral antianginal agent for angina symptom control in a patient with end-stage renal disease, the most directly targeted oral option for angina relief is an oral long-acting nitrate (isosorbide mononitrate or isosorbide dinitrate). [1][2]

Monotherapy Versus Combination Therapy

  • Monotherapy with an appropriate antianginal agent (beta blocker, CCB, or long-acting nitrate) can be used for angina symptom relief. [3]
  • Stepwise escalation is supported by adding an additional antianginal drug class (eg, adding a long-acting nitrate after first-line therapy) when symptoms persist. [1]

Important Clarifications and Nuances

  • Long-acting nitrates are used for angina symptom control. [1][3]
  • Nitrate tolerance is a clinically relevant limitation of long-acting nitrate therapy and requires nitrate-free or nitrate-low intervals in chronic regimens. [4]

Initiation Thresholds and Indications

  • Long-acting nitrates are indicated for angina symptom relief in chronic coronary disease when antianginal therapy is needed. [1][3]

Common Pitfalls to Avoid

  • Nitrate tolerance should be avoided by using appropriate dosing schedules that include a nitrate-free or nitrate-low interval. [4]

Targets or Goals of Therapy

  • The therapeutic goal is relief of angina symptoms with antianginal therapy. [3]

Related Questions